Reduce turn-around times with streamlined NGS Panels
Simple, robust and precise NGS enrichment for any target
We understand your pain points
- Insufficient starting material
- Labor costs
- Uneven coverage
- Costly reruns
- Unique targets
So we built a simpler solution
Enhanced sensitivity with PillarHS
PillarHS panels incorporate unique molecular IDs (UIDs, also called UMIs) for enhanced sensitivity. PillarHS panels are ideal for early detection or identifying minimally residual disease and are specifically designed for use with cell-free DNA.
Panels available for Illumina, MGI, and Thermo sequencers
Solid Tumor Panels
Targets include multi-cancer, breast, lung, and colon. Includes panels specialized to detect fusions and CNVs.
Blood Cancer Panels
Targets include myeloid cancers and myeloprolifitive neoplasm.
Inherited Disease Panels
Targets include cystic fibrosis, thalassemia, and BRCA1/BRCA2.
Custom Panels
Design your own custom panel with a one-day workflow via the ampPD™ primer design platform.
Find a panel that suits your targets or design your own
- All
- Solid tumors
- Blood cancers
- Inherited conditions
- Custom NGS
- PillarHS
ONCO/Reveal
Custom NGS Panels
Build your own NGS assay that fits your exact design criteria
ONCO/Reveal
BRCA1 & BRCA2 plus CNV Panel
Detect exon-level copy number variation (CNV) across the entire coding region of the BRCA1 and BRCA2 genes from FFPE or blood samples
ONCO/Reveal
Solid Tumor Panel
Interrogates key mutations in NSCLC, colorectal, pancreatic, GIST, thyroid cancer, melanomas, gliomas and other solid tumors
ONCO/Reveal
Myeloid NGS Panel
Interrogates 58 genes of interest most relevant to myeloid cancer
ONCO/Reveal
Essential MPN Panel
Simultaneously tests for key mutations within the MPL, JAK2, and CALR genes
ONCO/Reveal
Multi-Cancer v4
with CNV Panel
Interrogates genes of interest across multiple solid tumor cancer types for variants and CNVs
ONCO/Reveal
Multi-Cancer
RNA Fusion v2 Panel
Detect gene fusions in solid tumor samples for cancers including NSCLC, thyroid, and prostate cancer
ONCO/Reveal
Multi-Cancer
with CNV & RNA Fusion Panel
A combined DNA/RNA multi-cancer panel that reports on variants, CNVs and fusions
ONCO/Reveal
Multi-Cancer Panel
Interrogate 56 genes of interest across multiple solid tumor cancer types
ONCO/Reveal
PillarHS Multi-Cancer Panel
Interrogates 31 genes of interest across multiple solid tumor cancer types from cell-free DNA samples (liquid biopsies)
ONCO/Reveal
PillarHS Lung Panel
Interrogates 17 lung cancer genes of interest from liquid biopsy samples
ONCO/Reveal
Lung and Colon Cancer Panel
Interrogate 22 genes of interest that are focused on lung and colon cancer samples
ONCO/Reveal
Lung Fusion RNA Panel
Interrogates gene fusions across non-small cell lung cancer (NSCLC) samples
ONCO/Reveal
BRCA1 & BRCA2 Panel
Sequence the entire coding regions of the BRCA1 and BRCA2 genes plus 20bp of flanking introns
ONCO/Reveal
BRCA1 & BRCA2 Somatic Panel
Specifically designed with shorter amplicons to detect mutations in FFPE samples
ONCO/Reveal
TP53 Panel
Covers the entire CDS of the TP53 tumor suppressor gene
INHERIT/Reveal
CFTR Panel
Covers the entire CDS of the cystic fibrosis transmembrane conductance regulator (CFTR) gene; can multiplex up to 384 samples on a MiSeq cartridge
INHERIT/Reveal
Thalassemia Panel
Covers mutations in the hemoglobin alpha chain (HBA1 and HBA2) and beta chain (HBB), which are responsible for alpha and beta thalassemia
Coming soon!
-MSI
-cfDNA /cfRNA (single tube)
-Glioma
-HRD
-Lynch Syndrome
Dive straight into the feedback!Login below and you can start commenting using your own user instantly